2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]pyrimidin-4-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[4-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]-1,3,5-triazin-2-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis(dihexylcarbamoyl)phenyl]diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrahexylbenzene-1,4-dicarboxamide

C271H453N49O12 — CID 157176918

About 2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]pyrimidin-4-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[4-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]-1,3,5-triazin-2-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis(dihexylcarbamoyl)phenyl]diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrahexylbenzene-1,4-dicarboxamide

2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]pyrimidin-4-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[4-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]-1,3,5-triazin-2-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis(dihexylcarbamoyl)phenyl]diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrahexylbenzene-1,4-dicarboxamide (PubChem CID 157176918) has the molecular formula C271H453N49O12 and a molecular weight of 4589.94 g/mol. Its IUPAC name is 2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]pyrimidin-4-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[4-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]-1,3,5-triazin-2-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis(dihexylcarbamoyl)phenyl]diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrahexylbenzene-1,4-dicarboxamide.

Molecular Properties

• Compound Name: 2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]pyrimidin-4-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[4-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]-1,3,5-triazin-2-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis(dihexylcarbamoyl)phenyl]diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrahexylbenzene-1,4-dicarboxamide
• PubChem CID: 157176918
• Molecular Formula: C271H453N49O12
• Molecular Weight: 4589.94 g/mol
• Exact Mass: 4586.63
• IUPAC Name: 2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]pyrimidin-4-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[4-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]-1,3,5-triazin-2-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis(dihexylcarbamoyl)phenyl]diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrahexylbenzene-1,4-dicarboxamide
• SMILES: CCCCC(CC)CN(CC(CC)CCCC)C(=O)c1ccc(C(=O)N(CC(CC)CCCC)CC(CC)CCCC)c(/N=N/c2c(C(C)(C)C)nn(-c3cc(-n4nc(C(C)(C)C)c(/N=N/c5cc(C(=O)N(CC(CC)CCCC)CC(CC)CCCC)ccc5C(=O)N(CC(CC)CCCC)CC(CC)CCCC)c4N)ncn3)c2N)c1.CCCCC(CC)CN(CC(CC)CCCC)C(=O)c1ccc(C(=O)N(CC(CC)CCCC)CC(CC)CCCC)c(/N=N/c2c(C(C)(C)C)nn(-c3ncnc(-n4nc(C(C)(C)C)c(/N=N/c5cc(C(=O)N(CC(CC)CCCC)CC(CC)CCCC)ccc5C(=O)N(CC(CC)CCCC)CC(CC)CCCC)c4N)n3)c2N)c1.CCCCCCN(CCCCCC)C(=O)c1ccc(C(=O)N(CCCCCC)CCCCCC)c(/N=N/c2c(C)nn(-c3cc(-n4nc(C)c(/N=N/c5cc(C(=O)N(CCCCCC)CCCCCC)ccc5C(=O)N(CCCCCC)CCCCCC)c4N)ncn3)c2N)c1
• InChI: InChI=1S/C98H166N16O4.C97H165N17O4.C76H122N16O4/c1-23-39-47-71(31-9)62-109(63-72(32-10)48-40-24-2)93(115)79-55-57-81(95(117)111(66-75(35-13)51-43-27-5)67-76(36-14)52-44-28-6)83(59-79)103-105-87-89(97(17,18)19)107-113(91(87)99)85-61-86(102-70-101-85)114-92(100)88(90(108-114)98(20,21)22)106-104-84-60-80(94(116)110(64-73(33-11)49-41-25-3)65-74(34-12)50-42-26-4)56-58-82(84)96(118)112(68-77(37-15)53-45-29-7)69-78(38-16)54-46-30-8;1-23-39-47-70(31-9)61-109(62-71(32-10)48-40-24-2)90(115)78-55-57-80(92(117)111(65-74(35-13)51-43-27-5)66-75(36-14)52-44-28-6)82(59-78)103-105-84-86(96(17,18)19)107-113(88(84)98)94-100-69-101-95(102-94)114-89(99)85(87(108-114)97(20,21)22)106-104-83-60-79(91(116)110(63-72(33-11)49-41-25-3)64-73(34-12)50-42-26-4)56-58-81(83)93(118)112(67-76(37-15)53-45-29-7)68-77(38-16)54-46-30-8;1-11-19-27-35-47-87(48-36-28-20-12-2)73(93)61-43-45-63(75(95)89(51-39-31-23-15-5)52-40-32-24-16-6)65(55-61)81-83-69-59(9)85-91(71(69)77)67-57-68(80-58-79-67)92-72(78)70(60(10)86-92)84-82-66-56-62(74(94)88(49-37-29-21-13-3)50-38-30-22-14-4)44-46-64(66)76(96)90(53-41-33-25-17-7)54-42-34-26-18-8/h55-61,70-78H,23-54,62-69,99-100H2,1-22H3;55-60,69-77H,23-54,61-68,98-99H2,1-22H3;43-46,55-58H,11-42,47-54,77-78H2,1-10H3/b2*105-103+,106-104+;83-81+,84-82+
• InChIKey: AOCSHEZFUNHIIU-ZCBVEMELSA-N
• XLogP: 73.14
• TPSA: 745.31 Ų
• H-Bond Donors: 6
• H-Bond Acceptors: 49
• Rotatable Bonds: 166
• Heavy Atoms: 332
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	4589.94
LogP ≤ 5	73.14
H-Bond Donors ≤ 5	6
H-Bond Acceptors ≤ 10	49

Frequently Asked Questions

What is the IUPAC name of 2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]pyrimidin-4-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[4-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]-1,3,5-triazin-2-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis(dihexylcarbamoyl)phenyl]diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrahexylbenzene-1,4-dicarboxamide?

The IUPAC name of 2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]pyrimidin-4-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[4-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]-1,3,5-triazin-2-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis(dihexylcarbamoyl)phenyl]diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrahexylbenzene-1,4-dicarboxamide (CID 157176918) is 2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]pyrimidin-4-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[4-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]-1,3,5-triazin-2-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis(dihexylcarbamoyl)phenyl]diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrahexylbenzene-1,4-dicarboxamide.

What is the SMILES notation for 2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]pyrimidin-4-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[4-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]-1,3,5-triazin-2-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis(dihexylcarbamoyl)phenyl]diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrahexylbenzene-1,4-dicarboxamide?

The canonical SMILES for 2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]pyrimidin-4-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[4-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]-1,3,5-triazin-2-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis(dihexylcarbamoyl)phenyl]diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrahexylbenzene-1,4-dicarboxamide is CCCCC(CC)CN(CC(CC)CCCC)C(=O)c1ccc(C(=O)N(CC(CC)CCCC)CC(CC)CCCC)c(/N=N/c2c(C(C)(C)C)nn(-c3cc(-n4nc(C(C)(C)C)c(/N=N/c5cc(C(=O)N(CC(CC)CCCC)CC(CC)CCCC)ccc5C(=O)N(CC(CC)CCCC)CC(CC)CCCC)c4N)ncn3)c2N)c1.CCCCC(CC)CN(CC(CC)CCCC)C(=O)c1ccc(C(=O)N(CC(CC)CCCC)CC(CC)CCCC)c(/N=N/c2c(C(C)(C)C)nn(-c3ncnc(-n4nc(C(C)(C)C)c(/N=N/c5cc(C(=O)N(CC(CC)CCCC)CC(CC)CCCC)ccc5C(=O)N(CC(CC)CCCC)CC(CC)CCCC)c4N)n3)c2N)c1.CCCCCCN(CCCCCC)C(=O)c1ccc(C(=O)N(CCCCCC)CCCCCC)c(/N=N/c2c(C)nn(-c3cc(-n4nc(C)c(/N=N/c5cc(C(=O)N(CCCCCC)CCCCCC)ccc5C(=O)N(CCCCCC)CCCCCC)c4N)ncn3)c2N)c1.

What is the InChIKey of 2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]pyrimidin-4-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[4-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]-1,3,5-triazin-2-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis(dihexylcarbamoyl)phenyl]diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrahexylbenzene-1,4-dicarboxamide?

The InChIKey is AOCSHEZFUNHIIU-ZCBVEMELSA-N. The full InChI is InChI=1S/C98H166N16O4.C97H165N17O4.C76H122N16O4/c1-23-39-47-71(31-9)62-109(63-72(32-10)48-40-24-2)93(115)79-55-57-81(95(117)111(66-75(35-13)51-43-27-5)67-76(36-14)52-44-28-6)83(59-79)103-105-87-89(97(17,18)19)107-113(91(87)99)85-61-86(102-70-101-85)114-92(100)88(90(108-114)98(20,21)22)106-104-84-60-80(94(116)110(64-73(33-11)49-41-25-3)65-74(34-12)50-42-26-4)56-58-82(84)96(118)112(68-77(37-15)53-45-29-7)69-78(38-16)54-46-30-8;1-23-39-47-70(31-9)61-109(62-71(32-10)48-40-24-2)90(115)78-55-57-80(92(117)111(65-74(35-13)51-43-27-5)66-75(36-14)52-44-28-6)82(59-78)103-105-84-86(96(17,18)19)107-113(88(84)98)94-100-69-101-95(102-94)114-89(99)85(87(108-114)97(20,21)22)106-104-83-60-79(91(116)110(63-72(33-11)49-41-25-3)64-73(34-12)50-42-26-4)56-58-81(83)93(118)112(67-76(37-15)53-45-29-7)68-77(38-16)54-46-30-8;1-11-19-27-35-47-87(48-36-28-20-12-2)73(93)61-43-45-63(75(95)89(51-39-31-23-15-5)52-40-32-24-16-6)65(55-61)81-83-69-59(9)85-91(71(69)77)67-57-68(80-58-79-67)92-72(78)70(60(10)86-92)84-82-66-56-62(74(94)88(49-37-29-21-13-3)50-38-30-22-14-4)44-46-64(66)76(96)90(53-41-33-25-17-7)54-42-34-26-18-8/h55-61,70-78H,23-54,62-69,99-100H2,1-22H3;55-60,69-77H,23-54,61-68,98-99H2,1-22H3;43-46,55-58H,11-42,47-54,77-78H2,1-10H3/b2*105-103+,106-104+;83-81+,84-82+.

What are the key properties of 2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]pyrimidin-4-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[4-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]-1,3,5-triazin-2-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis(dihexylcarbamoyl)phenyl]diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrahexylbenzene-1,4-dicarboxamide?

2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]pyrimidin-4-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[4-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]-1,3,5-triazin-2-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis(dihexylcarbamoyl)phenyl]diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrahexylbenzene-1,4-dicarboxamide has a molecular weight of 4589.94 g/mol, XLogP of 73.14, 166 rotatable bonds, 6 hydrogen bond donors, and 49 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]pyrimidin-4-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[4-[5-amino-4-[[2,5-bis[bis(2-ethylhexyl)carbamoyl]phenyl]diazenyl]-3-tert-butylpyrazol-1-yl]-1,3,5-triazin-2-yl]-3-tert-butylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrakis(2-ethylhexyl)benzene-1,4-dicarboxamide;2-[[5-amino-1-[6-[5-amino-4-[[2,5-bis(dihexylcarbamoyl)phenyl]diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-1-N,1-N,4-N,4-N-tetrahexylbenzene-1,4-dicarboxamide is sourced from PubChem (CID 157176918), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).